Study at a glance
How was vitamin D studied in diabetes and small blood vessels?
This page compares a study of vitamin D3 in people with type 2 diabetes and nerve damage with a laboratory study of blood-vessel lining cells exposed to high glucose. They examined possible effects on small-vessel function and cell injury. They did not test the same treatment or prove one complete pathway from supplements to prevention of diabetic complications.
What did the vitamin D3 study in people with diabetes report?
Sixty-seven people were assigned to two weekly vitamin D3 doses for 24 weeks, and 62 completed follow-up. The higher-dose group had reported improvements in selected toe-skin blood-flow tests and two immune signals, while several other measured signs of inflammation did not change significantly. Weight and glucose control also improved. There was no placebo group, the way people were assigned to groups was predictable and treatment was known. Inconsistent reporting of some flow results limits precise conclusions.
What did active vitamin D change in cells exposed to high glucose?
Active vitamin D reduced some injury signals and improved survival-related measurements and movement in cells grown in the laboratory. Increasing a protein called TIPE1 opposed several effects. This suggests a possible role for the protein, but does not establish the whole mechanism. The experiment had only three independent repetitions and lacked a control needed to separate glucose-specific effects from other effects of the solution. Computer predictions about receptor binding were not directly confirmed.
Do these findings establish nerve repair or prevention of diabetic complications?
The human study did not measure TIPE1, and the cell experiment did not measure blood flow in a person. A small change in a pain score does not establish a large health benefit or nerve repair. The separate blood-sample comparison was observational, so it could not prove cause and effect. These studies do not establish improved nerve oxygen delivery, prevention of kidney or eye complications, an ideal dose or general treatment safety.
Read the full article below ↓Two studies examined different parts of the proposed link between vitamin D and diabetic microvascular stress. A human trial reported changes in skin blood-flow measurements and selected inflammatory markers; a laboratory study tested high-glucose injury in endothelial cells. Important design and reporting limitations prevent treating them as proof that vitamin D prevents diabetic complications. For the detailed methods and appraisal, read Vitamin D, Diabetic Microvascular Dysfunction and Metabolic Stress: Full Study.
What the human trial found
Karonova and colleagues allocated 67 people with type 2 diabetes and neuropathy to 5,000 or 40,000 international units of vitamin D3 weekly for 24 weeks. Sixty-two completed follow-up. The even/odd allocation method was predictable, treatment was open label and there was no placebo group. Registration occurred after study completion. These features limit the strength of the treatment comparison.
The higher-dose group showed reported improvement in toe-skin flow indices, lower interleukin-6 and higher interleukin-10, two immune signalling proteins. Several other inflammatory markers did not change significantly. However, the microcirculation table has inconsistent descriptions of variability, and the prose and table disagree about one lower-dose flow result. Precise effect claims require caution.
This is evidence about measured skin microcirculation, not direct oxygen delivery to nerves. Weight and glucose control also improved in the higher-dose group, leaving direct vascular action versus indirect metabolic explanations unresolved. The median pain score changed only from 50 to 47 on a 100-mm scale; statistical significance does not establish a large clinical benefit or nerve repair.
What the cell study adds
Liu and colleagues exposed human umbilical vein endothelial cells to high glucose, then treated them with calcitriol, the active vitamin D hormone. Selected injury signals fell and viability and migration improved. Increasing a protein called TIPE1, tumour necrosis factor alpha-induced protein 8-like 1, opposed several responses. This supports investigation of a cellular pathway within endothelial function.
The experiment used three independent replicates, a large-vessel cell model and no reported matched osmotic control. Computer-predicted vitamin D receptor binding sites were not confirmed by direct promoter-binding experiments. A separate comparison of blood samples from people with and without complications was observational, not a supplementation trial.
Why the mechanism remains unresolved
The clinical trial did not measure TIPE1, and the cell experiment did not measure blood flow in a person. Neither directly tested metabolic flexibility, the ability to adapt fuel use, despite the relevance of metabolic stress to their questions. Changes observed at different biological levels cannot be assembled into a proven treatment pathway.
The findings support more rigorous research with clearer reporting and direct clinical outcomes. They do not establish an optimal supplement dose, general safety, improved nerve oxygenation or prevention of kidney, retinal or other diabetic complications. The high-dose regimen and achieved blood concentrations are study details, not recommendations.
Scientific sources
Karonova T, Stepanova A, Bystrova A, Jude EB. High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients. Nutrients. 2020;12:2518. DOI: 10.3390/nu12092518. PMID: 32825324. The complete principal paper, participant flow diagram and three tables were examined.
Liu Z, Sun H, Chen Y, He J, Zhu L, Yang B, Zhao W. High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation through downregulation of TIPE1. Diabetology & Metabolic Syndrome. 2024;16:18. DOI: 10.1186/s13098-024-01264-5. PMID: 38216955. The complete principal paper, all six figures and clinical table were examined.
ClinicalTrials.gov. High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy. NCT04377399. First posted 6 May 2020, after the recorded study completion. This is the registration for the Karonova trial, not an independent efficacy study.
Related reading
Aqueous humor and serum 25-Hydroxyvitamin D levels in patients with cataracts
This study investigated the possible correlations between 25 (OH) D concentrations in aqueous humor and serum and whether vitamin D concentrations in aqueous humor were associated with cataract.
Original paper ↗Read more →Metformin Use Is Not Associated With B12 Deficiency or Neuropathy in Patients With Type 2 Diabetes Mellitus in Qatar
Metformin may lead to B12 deficiency and neuropathy.
Original paper ↗Read more →Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study
This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis (HD) patients with or without diabetes.
Original paper ↗Read more →The Association of Gene Variants in the Vitamin D Metabolic Pathway and Its Interaction with Vitamin D on Gestational Diabetes Mellitus: A Prospective Cohort Study
The present prospective study included 2156 women and investigated the effect of gene variants in the vitamin D (VitD) metabolic and glucose pathways and their interaction with VitD levels during pregnancy on gestational diabetes mellitus (GDM).
Original paper ↗Read more →Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar
We aim to evaluate the safety and effectiveness of FDC and ST regimen for treating PTB, in addition to comparing safety and efficacy of FDC and ST regimens in patients with diabetes treated for TB.
Original paper ↗Read more →Vitamin D in Neurological Diseases
Vitamin D may have multiple effects on the nervous system and its deficiency can represent a possible risk factor for the development of many neurological diseases.
Original paper ↗Read more →High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation through downregulation of TIPE1
Diabetes mellitus (DM) and its associated vascular complications have become a worldwide health concern.
Original paper ↗Read more →Vitamin D, Diabetic Microvascular Dysfunction and Metabolic Stress: Full Study
Assess vitamin D studies of diabetic microvascular dysfunction, metabolic stress and cellular injury, separating clinical measurements from proposed mechanisms.
Read more →Changes of Serum Bone Metabolism Indexes and Ultrasonic Bone Mineral Density in Patients with Diabetic Nephropathy at Different Stages and their effects on Diabetic Renal Microvascular Complications
Differences in serum bone metabolism indexes and ultrasound BMD levels were compared.
Original paper ↗Read more →The Relationship between Selected Inflammation and Oxidative Stress Biomarkers and Carotid Intima-Media Thickness (IMT) Value in Youth with Type 1 Diabetes Co-Existing with Early Microvascular Complications
Recent years have confirmed the importance of oxidative stress and biomarkers of inflammation in estimating the risk of cardiovascular disease (CVD) and explaining not fully understood pathogenesis of diabetic macroangiopathy.
Original paper ↗Read more →Association of vitamin D2 and D3 with type 2 diabetes complications
Four hundred ninety-six Qatari subjects, 274 with and 222 without T2DM participated in the study.
Original paper ↗Read more →Association of Vitamin D Deficiency with Diabetic Nephropathy in Type 2 Diabetes: A Hospital-Based Cross-Sectional Study
Background/Objective: Diabetic nephropathy (DN), a key microvascular complication of type 2 diabetes (T2DM), drives significant morbidity, mortality, and healthcare costs.
Original paper ↗Read more →Association of Vitamin D Deficiency with Diabetic Nephropathy in Type 2 Diabetes: A Hospital-Based Cross-Sectional Study
Background/Objective: Diabetic nephropathy (DN), a key microvascular complication of type 2 diabetes (T2DM), drives significant morbidity, mortality, and healthcare costs.
Original paper ↗Read more →Identifying Diabetic Kidney Disease in Type 2 Diabetes Patients Using Explainable Machine Learning: A Case‐Control Study
This research focused on establishing and testing a machine learning: driven predictive tool aimed at assisting in the identification of diabetic kidney disease (DKD).
Original paper ↗Read more →Impact of vitamin D on glycemic control and microvascular complications in type 2 diabetes: A cross-sectional study
The mean BMI was 28.91 kg/m², and 29.1% of participants had vitamin D deficiency.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Retinal Structural and Microvascular Findings on OCT and OCTA in Hemodialysis and Kidney Transplant Recipients and Their Association with Mineral Metabolism Parameters
Background: Chronic kidney disease (CKD) is associated with systemic microvascular dysfunction, yet the relationship between retinal changes and mineral metabolism disturbances across CKD treatment modalities remains incompletely characterized.
Original paper ↗Read more →The association between bone turnover markers and microvascular complications of type 2 diabetes
The aim of this study was to assess whether bone turnover markers are associated with diabetes micro-vascular complications.
Original paper ↗Read more →The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus
In this study, we investigated the frequency of 25-OH vitamin D deficiency in type 2 diabetes mellitus and the relationship between 25-OH vitamin D deficiency and the prevalence of microvascular complications.
Original paper ↗Read more →Vitamin D and cardiovascular autonomic neuropathy in type 2 diabetes mellitus according to diabetic kidney disease stage
We evaluated the relationship between serum VD and CAN in patients with type 2 Diabetes Mellitus (T2DM) in early and advanced stages of DKD.
Original paper ↗Read more →Vitamin D and Microcirculation
Explore how vitamin D participates in microcirculation through endothelial signalling, vascular tone, immune interaction, and tissue-level blood flow regulation.
Read more →Original sources
High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients
Published in Nutrients (2020).
Publication details
Karonova T, Stepanova A, Bystrova A, Jude EB. High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients. Nutrients. 2020;12:2518. DOI: 10.3390/nu12092518. PMID: 32825324. The complete principal paper, participant flow diagram and three tables were examined.
High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation through downregulation of TIPE1
Published in Diabetology & Metabolic Syndrome (2024).
Publication details
Liu Z, Sun H, Chen Y, He J, Zhu L, Yang B, Zhao W. High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation through downregulation of TIPE1. Diabetology & Metabolic Syndrome. 2024;16:18. DOI: 10.1186/s13098-024-01264-5. PMID: 38216955. The complete principal paper, all six figures and clinical table were examined.
High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy
ClinicalTrials.gov. High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy.
Publication details
ClinicalTrials.gov. High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy. NCT04377399. First posted 6 May 2020, after the recorded study completion. This is the registration for the Karonova trial, not an independent efficacy study.